140 related articles for article (PubMed ID: 1906347)
21. N-arylazido-beta-alanyl-NAD+, a new NAD+ photoaffinity analogue. Synthesis and labeling of mitochondrial NADH dehydrogenase.
Deng PS; Hatefi Y; Chen S
Biochemistry; 1990 Jan; 29(4):1094-8. PubMed ID: 2340277
[TBL] [Abstract][Full Text] [Related]
22. Synthesis of the photoaffinity probe 3-(p-azidobenzyl)-4-hydroxycoumarin and identification of the dicoumarol binding site in rat liver NAD(P)H:quinone reductase (EC 1.6.99.2).
Myszka DG; Swenson RP
J Biol Chem; 1991 Mar; 266(8):4789-97. PubMed ID: 1705934
[TBL] [Abstract][Full Text] [Related]
23. X-ray diffraction analyses of crystals of rat liver NAD(P)H:(quinone-acceptor) oxidoreductase containing cibacron blue.
Ysern X; Prochaska HJ
J Biol Chem; 1989 May; 264(14):7765-7. PubMed ID: 2498304
[TBL] [Abstract][Full Text] [Related]
24. Kinetics of glutathione transferase, glutathione transferase messenger RNA, and reduced nicotinamide adenine dinucleotide (phosphate):quinone reductase induction by 2(3)-tert-butyl-4-hydroxyanisole in mice.
Benson AM; Hunkeler MJ; Morrow JF
Cancer Res; 1984 Nov; 44(11):5256-61. PubMed ID: 6435866
[TBL] [Abstract][Full Text] [Related]
25. Photodependent incorporation of arylazido-beta-alanyl-NAD+ into the coenzyme binding site of yeast glyceraldehyde-3-phosphate dehydrogenase.
Bayne S; Sund H; Guillory RJ
Biochimie; 1981 Jul; 63(7):569-73. PubMed ID: 7025921
[TBL] [Abstract][Full Text] [Related]
26. Lapachol inhibition of DT-diaphorase (NAD(P)H:quinone dehydrogenase).
Preusch PC
Biochem Biophys Res Commun; 1986 Jun; 137(2):781-7. PubMed ID: 3089219
[TBL] [Abstract][Full Text] [Related]
27. 3-Azidodibenzofuran, a photoactivated inhibitor for reduced nicotinamide--adenine dinucleotide--ubiquinone reductase [proceedings].
Earley FG; Bloxham DP
Biochem Soc Trans; 1978; 6(6):1305-7. PubMed ID: 217780
[No Abstract] [Full Text] [Related]
28. Catalytic properties of NAD(P)H:quinone acceptor oxidoreductase: study involving mouse, rat, human, and mouse-rat chimeric enzymes.
Chen S; Knox R; Lewis AD; Friedlos F; Workman P; Deng PS; Fung M; Ebenstein D; Wu K; Tsai TM
Mol Pharmacol; 1995 May; 47(5):934-9. PubMed ID: 7746280
[TBL] [Abstract][Full Text] [Related]
29. Menadione- (2-methyl-1,4-naphthoquinone-) dependent enzymatic redox cycling and calcium release by mitochondria.
Frei B; Winterhalter KH; Richter C
Biochemistry; 1986 Jul; 25(15):4438-43. PubMed ID: 3092856
[TBL] [Abstract][Full Text] [Related]
30. Glucocorticoid regulation of polycyclic aromatic hydrocarbon induction of cytochrome P450IA1, glutathione S-transferases, and NAD(P)H:quinone oxidoreductase in cultured fetal rat hepatocytes.
Sherratt AJ; Banet DE; Prough RA
Mol Pharmacol; 1990 Feb; 37(2):198-205. PubMed ID: 2304451
[TBL] [Abstract][Full Text] [Related]
31. Reduction of mitomycin C is catalysed by human recombinant NRH:quinone oxidoreductase 2 using reduced nicotinamide adenine dinucleotide as an electron donating co-factor.
Jamieson D; Tung AT; Knox RJ; Boddy AV
Br J Cancer; 2006 Nov; 95(9):1229-33. PubMed ID: 17031400
[TBL] [Abstract][Full Text] [Related]
32. Structure-function relationship of NAD(P)H:quinone reductase: characterization of NH2-terminal blocking group and essential tyrosine and lysine residues.
Haniu M; Yuan H; Chen SA; Iyanagi T; Lee TD; Shively JE
Biochemistry; 1988 Sep; 27(18):6877-83. PubMed ID: 3143406
[TBL] [Abstract][Full Text] [Related]
33. Nucleotide and deduced amino acid sequence of a human cDNA (NQO2) corresponding to a second member of the NAD(P)H:quinone oxidoreductase gene family. Extensive polymorphism at the NQO2 gene locus on chromosome 6.
Jaiswal AK; Burnett P; Adesnik M; McBride OW
Biochemistry; 1990 Feb; 29(7):1899-906. PubMed ID: 1691923
[TBL] [Abstract][Full Text] [Related]
34. Mouse liver NAD(P)H:quinone acceptor oxidoreductase: protein sequence analysis by tandem mass spectrometry, cDNA cloning, expression in Escherichia coli, and enzyme activity analysis.
Chen S; Clarke PE; Martino PA; Deng PS; Yeh CH; Lee TD; Prochaska HJ; Talalay P
Protein Sci; 1994 Aug; 3(8):1296-304. PubMed ID: 7527260
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of mitochondrial NADH:ubiquinone oxidoreductase by ethoxyformic anhydride.
Vik SB; Hatefi Y
Biochem Int; 1984 Nov; 9(5):547-55. PubMed ID: 6441575
[TBL] [Abstract][Full Text] [Related]
36. Mitomycin C is not metabolized by but is an inhibitor of human kidney NAD(P)H: (quinone-acceptor)oxidoreductase.
Schlager JJ; Powis G
Cancer Chemother Pharmacol; 1988; 22(2):126-30. PubMed ID: 3136941
[TBL] [Abstract][Full Text] [Related]
37. Histochemical detection of quinone reductase activity in situ using LY 83583 reduction and oxidation.
Murphy TH; So AP; Vincent SR
J Neurochem; 1998 May; 70(5):2156-64. PubMed ID: 9572303
[TBL] [Abstract][Full Text] [Related]
38. Advances in research on DT-diaphorase--catalytic properties, regulation of activity and significance in the detoxication of foreign compounds.
Horie S
Kitasato Arch Exp Med; 1990 Apr; 63(1):11-30. PubMed ID: 2125671
[TBL] [Abstract][Full Text] [Related]
39. Photoaffinity inhibition of rat liver NAD(P)H dehydrogenase by 3-(alpha-acetonyl-p-azidobenzyl)-4-hydroxycoumarin.
Almeda S; Bing DH; Laura R; Friedman PA
Biochemistry; 1981 Jun; 20(13):3731-7. PubMed ID: 7272275
[TBL] [Abstract][Full Text] [Related]
40. Regeneration of lipophilic antioxidants by NAD(P)H:quinone oxidoreductase 1.
Bello RI; Kagan VE; Tyurin V; Navarro F; Alcaín FJ; Villalba JM
Protoplasma; 2003 May; 221(1-2):129-35. PubMed ID: 12768350
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
